Methylprednisolone Acetate Injectable Suspension Lacks Sterility Assurance
Teva Pharmaceuticals is recalling Methylprednisolone Acetate Injectable Suspension 400 mg/10mL due to lack of assurance of sterility. The recall affects one lot distributed to facilities in Tennessee, Mississippi, and Ohio.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of an injectable pharmaceutical product. Injectable medications with sterility concerns pose a significant risk of serious infection and potential for hospitalization if sterile barriers are compromised, meeting the Severe category criteria for Class II recalls with serious injury potential.
Plain-English summary
Teva Pharmaceuticals USA is recalling Methylprednisolone Acetate Injectable Suspension USP 400 mg/10mL (40 mg/mL), 10 mL Multiple-Dose Vials, manufactured for Northstar Rx LLC in Memphis, TN. The recall has been issued due to lack of assurance of sterility in the recalled product.
Affected product: Methylprednisolone Acetate Injectable Suspension USP 400 mg/10mL (40 mg/mL), 10 mL Multiple-Dose Vials, Rx Only, NDC 16714-090-01, Lot #100022393 with expiration date 09/2022. Approximately 7,400 cartons were distributed.
The product was distributed to facilities in Tennessee, Mississippi, and Ohio. Healthcare providers and patients who have received this product should consult their healthcare provider regarding potential exposure. Patients should not stop taking this medication without speaking to their healthcare provider first, as abrupt discontinuation may pose health risks.
The recalled product
- Product
- MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 16714-090-01, packaged in cartons.
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Injectable Suspension
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 100022393
- exp 09/2022
Distribution
Distributed in 3 states:
- MS
- OH
- TN
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27